Hon CHRIS HIPKINS: Well, no, actually, reliable diagnostic testing—and everybody around rapid antigen tests would agree that they are not a diagnostic test. They are a surveillance test, not a diagnostic test. So the provisions in this bill deal with the provisions around diagnostic testing, which is critical in a severe outbreak. The issues around rapid antigen testing are different, and it does have a significant role to play in reducing the pressure on our diagnostic tests, because if we are using rapid antigen tests to do some of the surveillance testing—which we are moving to doing more and more of them; that's already happening—that means that it frees up our PCR labs, effectively, to make sure that they're being used in the best way possible.